Today: 29 April 2026
Citigroup stock edges higher as Citi emerges in $200 billion Glencore-Rio Tinto talks
2 February 2026
2 mins read

Citigroup stock edges higher as Citi emerges in $200 billion Glencore-Rio Tinto talks

New York, Feb 2, 2026, 15:43 (EST) — Regular session underway.

  • Citigroup shares climbed roughly 0.8% to $116.63, bouncing back from an earlier dip to $114.40.
  • A report indicated that Glencore is nearing a deal to appoint Citi as lead adviser ahead of potential discussions with Rio Tinto, eyeing a crucial U.K. deadline on Feb. 5.
  • On Monday, a Federal Reserve survey showed stronger expectations for business-loan demand in 2026.

Citigroup shares climbed around 0.8% to $116.63 Monday afternoon, after bouncing between $114.40 and $116.97 earlier. Investors digested news that Glencore is nearing a deal to appoint Citi as lead adviser in potential merger talks with Rio Tinto, aiming to create a mining giant valued over $200 billion. The UK Takeover Panel has set a “put up or shut up” deadline for these deals, requiring a firm offer or withdrawal by Feb. 5. Reuters

Why it matters now: Citi’s stock is often seen as a barometer for two volatile factors — deal fees and interest rate movements. While landing a major advisory mandate won’t boost earnings immediately, it fuels the investment banking story in a market prone to punishing banks whenever activity slows down.

The boost was broad in financials. Financial Select Sector SPDR Fund climbed around 1.0%, and the SPDR S&P Bank ETF added about 1.7%. Bank of America rose over 1%, with Wells Fargo jumping more than 2%.

In the Glencore case, Rio Tinto has tapped Evercore and Macquarie Group as advisers, with other banks also vying for a spot, the report noted. Citi’s relationship with Glencore stretches back years, covering its 2011 IPO and the recent acquisition of Teck Resources’ coal unit. Both Glencore and Citi declined to comment.

A fresh data point also helped the sector tone. A quarterly Federal Reserve survey revealed banks anticipate stronger demand for business loans in 2026, citing lower rates and increased spending or investment needs as key factors. The Fed held its benchmark rate steady last week at 3.50%-3.75% and indicated inflation and labor-market conditions may delay any further cuts “for some time,” the report noted. Reuters

Citi reported that investment-banking fees jumped 35% to $1.29 billion in the last quarter, driven by a boost in dealmaking. The bank highlighted a broader uptick in services to corporate clients as mergers and acquisitions gained momentum late last year.

Monday’s action carried a clear macro tilt. “The key thing that seemed to turn sentiment today is a push back to focusing on fundamentals,” said Carol Schleif, chief market strategist at BMO Private Wealth. Investors are bracing for a busy week filled with earnings reports and central bank meetings. Reuters

Citi’s board has set a quarterly common dividend at $0.60 per share. It’s payable on Feb. 27 to shareholders on record as of Feb. 2 — the deadline to qualify for the payout.

Still, the deal talk remains just that — talk. Major merger discussions often stall or fall apart, and the advisory fees won’t materialize until a deal is officially inked and completed.

Investors have two key dates coming up fast. Feb. 5 marks the U.K. takeover deadline linked to the Glencore-Rio Tinto talks. Then on Feb. 27, Citi is set to pay its dividend.

Stock Market Today

  • Nasdaq Futures Rise Ahead of Fed Decision and Major Tech Earnings
    April 29, 2026, 9:10 AM EDT. Nasdaq futures gained 0.4% ahead of the Federal Reserve's policy decision and earnings reports from tech giants Alphabet, Microsoft, Amazon, and Meta. Markets are cautious following a broad sell-off in major indices driven by chip stock weakness linked to slowing growth at AI firm OpenAI. Investors await the Fed's stance on inflation and interest rates, with crude oil prices rising amid unresolved US-Iran tensions. The Fed is expected to hold rates steady in Jerome Powell's final meeting before his replacement, Kevin Warsh, awaits Senate approval. Key focus remains on AI capital expenditure and the potential for further rate hikes in 2024. Earnings from AbbVie, AstraZeneca, Total Energies, UBS, and GSK are also in focus.

Latest article

Regeneron Earnings Beat, But Eylea Still Clouds REGN Stock

Regeneron Earnings Beat, But Eylea Still Clouds REGN Stock

29 April 2026
Regeneron Pharmaceuticals reported first-quarter revenue of $3.605 billion, up 19%, and adjusted earnings of $9.47 per share, both above analyst estimates. Dupixent sales rose 33% and Libtayo 54%, while total U.S. Eylea sales fell 10%. Shares dropped 1.1% premarket. The FDA delayed a decision on a second Eylea HD syringe manufacturer; Regeneron cut its 2026 gross-margin forecast due to repairs in Ireland.
Humana Stock Drops After Earnings Beat: Medicare Advantage Headwind Keeps Pressure On

Humana Stock Drops After Earnings Beat: Medicare Advantage Headwind Keeps Pressure On

29 April 2026
Humana beat first-quarter profit estimates, earning $10.31 per share adjusted, but shares fell over 6% premarket after it kept its 2026 profit outlook unchanged and cut its GAAP earnings forecast. Revenue rose to $39.65 billion. The insurer cited lower Medicare Star Ratings for the earnings decline and said medical and pharmacy costs are “slightly better” than expected. Competitors Centene, UnitedHealth, and Elevance recently raised their annual forecasts.
Cisco stock pops to a fresh 52-week high — here’s what Wall Street is watching next
Previous Story

Cisco stock pops to a fresh 52-week high — here’s what Wall Street is watching next

Nebius (NBIS) stock rebounds after a wild session as Feb. 12 results loom
Next Story

Nebius (NBIS) stock rebounds after a wild session as Feb. 12 results loom

Go toTop